New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NVS;MOS;SCCO;ADM;IP From The Last 14 Days
Check below for free stories on NVS;MOS;SCCO;ADM;IP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
July 31, 2014
07:06 EDTMOSMosaic sees FY14 CapEx $1B-$1.2B, down $200M due to deferral of expenditures
Subscribe for More Information
07:05 EDTMOSMosaic expects strong demand for phosphates and potash in Q3
Subscribe for More Information
07:04 EDTMOSMosaic: Very strong global demand for phosphates pushed prices higher
The company said potash demand also exceeded expectations. Reports Q2 Phosphates segment sales $1.7B. Mosaic's North American finished phosphate production was 2.5 million tonnes. Reports Q2 Potash segment sales $762M. Potash production was 2.0 million tonnes, or 76% of operational capacity.
07:02 EDTMOSMosaic reports Q2 EPS 64c, compared to $1.01 a year ago
Subscribe for More Information
July 30, 2014
15:12 EDTMOSMosaic buys 3.09M shares back from MAC Trusts
Subscribe for More Information
10:37 EDTNVSInnoPharma announces launch of generic Zyprexa in Canada
Subscribe for More Information
10:00 EDTIPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTIP, IPInternational Paper downgraded to Underperform from Outperform at CLSA
Subscribe for More Information
07:25 EDTIP, IPInternational Paper downgraded to Underperform from Outperform at CLSA
July 29, 2014
07:07 EDTIPInternational Paper reports Q2 Industrial Packaging operating profit $534M
Subscribe for More Information
07:06 EDTIPInternational Paper reports Q2 operating EPS 95c, consensus 83c
Subscribe for More Information
05:19 EDTNVSNovartis sees high uptake in meningitis B vaccination program
Subscribe for More Information
July 28, 2014
15:47 EDTIPNotable companies reporting before tomorrow's open
Subscribe for More Information
12:05 EDTIPOptions with increasing implied volatility
Subscribe for More Information
05:30 EDTNVSAlcon announces Simbrinza approved in EU
Subscribe for More Information
July 25, 2014
08:08 EDTIPMLP potential could serve as floor for stocks, says Deutsche Bank
Subscribe for More Information
July 24, 2014
13:20 EDTIPInternational Paper volatility elevated on Perry Capital taking position
Subscribe for More Information
13:16 EDTIPContainerboard names rally with Perry seeing 50%-100% upside
Richard Perry's Perry Capital took positions or increased holdings during Q2 in containerboard names International Paper (IP), RockTenn (RKT), KapStone (KS) and Packaging Corp. (PKG), Bloomberg reports. Perry believes managements can create master limited partnerships for their paper mills, driving share upside potential of 50%-100%, Bloomberg cites Perry as stating in the fundís Q2 letter. Shares of containerboard names are rallying today, with International Paper up 5%, RockTenn and KapStone up 9%, and Packaging Corp. up 4% in afternoon trading. Perry Capital has $10.9B under management, according to Bloomberg.
10:37 EDTIPOptions with increasing implied volatility: TLM IP HSH
Subscribe for More Information
05:41 EDTNVSNovartis announces FDA acceptance of Sandoz application for filgrastim
Sandoz, a Novartis Group company, announced that the FDA has accepted its Biologics License Application for filgrastim, which was filed under the new biosimilar pathway created in the Biologics Price Competition and Innovation Act of 2009.
July 23, 2014
13:51 EDTMOSEarnings Preview: Potash sees Q2 earnings per share 40c-45c
Subscribe for More Information
10:02 EDTSCCOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:49 EDTSCCOSouthern Copper upgraded to Buy from Neutral at UBS
Subscribe for More Information
08:34 EDTMOSMosaic to permanently discontinue production of MOP at Carlsbad facility
Mosaic said in a filing that on July 21 it decided to permanently discontinue production of muriate of potash at its Carlsbad, New Mexico facility. The final date for production is expected to be December 31. The decision is based on the quality of the ore in the Carlsbad basin and the age of the facility's infrastructure. These combined factors make it difficult for the operations to remain competitive in an already challenging global market. The discontinuation of this product at Carlsbad is a further step in our previously announced ongoing asset optimization initiatives. Its larger potash production facilities at Esterhazy, Belle Plaine and Colonsay in Saskatchewan, Canada will continue to produce MOP.Mosaicís plan for the immediate future is to transition the Carlsbad facility to the exclusive production of its highly valued K-Mag product line. K-Mag is a premium potash product that currently represents approximately 70% of production at the Carlsbad facility and is a long-term strategic asset for us.We currently estimate that the discontinued production will result in total pre-tax charges in the range of $135M-$160M. The third quarter pre-tax charges are estimated to be in the range of $55M-$77M with the majority of the remainder expected to be recorded in the fourth quarter.
06:41 EDTNVSArray BioPharma shares attractive at current levels, says Piper Jaffray
Piper Jaffray says shares of Array BioPharma are attractive at current levels ahead of Phase III data readouts for binimetinib in melanoma, selumetinib in Kras-mutant lung, thyroid and uveal melanoma, and filanesib in multiple myeloma. Piper sees the biggest overhang on Array shares as being the financing requirement and it notes that binimetinib could be returned to the company from current partner Novartis (NVS). Nonetheless, it feels investors should take a "serious look" at Array and keeps an Overweight rating on the stock with a $9 price target.
05:53 EDTIPStocks with implied volatility movement; IP AMAT
Subscribe for More Information
July 22, 2014
10:00 EDTIPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:49 EDTIPInternational Paper downgraded to Buy from Conviction Buy at Goldman
Goldman removed International Paper from the Conviction Buy List and maintains it Buy rating to reflect increased risk to a potential decline in containerboard prices. The firm notes the first reduction in semi-chemical medium prices since Q4 2008 occurred in July, indicating the market may be weaker than expected.
July 21, 2014
09:00 EDTIPInternational Paper downgraded to Neutral from Outperform at Macquarie
Subscribe for More Information
07:55 EDTIPJuly containerboard medium prices decline $10, says Deutsche Bank
Subscribe for More Information
07:38 EDTNVSNovartis management to meet with JPMorgan
Meetings to be held in Los Angeles/Pasadena on July 24 and in San Francisco on July 25 hosted by JPMorgan.
07:11 EDTNVSInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
07:03 EDTNVSAnacor, Sandoz enter into agreement for commercialization of Kerydin in the U.S.
Anacor Pharmaceuticals (ANAC) announced that it has entered into an exclusive agreement with Sandoz, a Novartis (NVS) company, pursuant to which Sandoz will distribute and commercialize Anacorís drug KERYDIN topical solution, 5% in the United States. PharmaDerm, the branded dermatology business of Sandoz, will be responsible for the sales and marketing of KERYDIN. On July 8, Anacor announced that the U.S. FDA approved the New Drug Application for KERYDIN, the first oxaborole antifungal approved for the topical treatment of onychomycosis of the toenails, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States, according to Podiatry Today. The agreement with Sandoz entitles Anacor to upfront payments totaling $40M and an additional milestone payment of $25M expected to be paid in January 2015. Under the agreement, Sandoz and Anacor will share equally, under a long-term profit-sharing arrangement, the gross profits accrued by Sandoz on sales of KERYDIN, except that in 2015 Anacor will start receiving profit-sharing payments after the first $50M of gross profits have been accrued by Sandoz. The long-term profit-sharing arrangement includes cumulative minimum profit-sharing payments to Anacor in 2016 totaling $45M. Anacor will also have the option to repurchase all rights in KERYDIN from Sandoz on the later of three years from launch or December 31, 2017, at a price to be determined pursuant to the agreement. Under the terms of the agreement, Anacor will supply product to Sandoz at cost through Anacorís contract manufacturers, and Sandoz will be responsible for all of its selling, marketing, distribution, general and administrative costs related to the commercialization of KERYDIN. Anacor will hold the NDA and will be responsible for any further development of KERYDIN.
July 18, 2014
08:31 EDTMOSPotash Corp BG Mosaic could become BHP takeover targets, says Bernstein
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use